Differenze tra le versioni di "Emtricitabina"
(→SPECIALITÀ) |
(→SPECIALITÀ) |
||
| Riga 3: | Riga 3: | ||
*'''[[Emtriva]]''' [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000527/WC500026532.pdf''monografia] 1FL 30CPS 200MG, OS SOL 1FL 170ML | *'''[[Emtriva]]''' [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000527/WC500026532.pdf''monografia] 1FL 30CPS 200MG, OS SOL 1FL 170ML | ||
| − | '''EMTRICITABINA/TENOFOVIR DISOPROXIL''' | + | '''EMTRICITABINA/[[Tenofovir|TENOFOVIR]] DISOPROXIL''' |
*'''[[Truvada]]''' [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000594/WC500043715.pdf''monografia''] 30CPR RIV 200MG/245MG | *'''[[Truvada]]''' [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000594/WC500043715.pdf''monografia''] 30CPR RIV 200MG/245MG | ||
| − | '''EFAVIRENZ/EMTRICITABINA/TENOFOVIR DISOPROXIL''' | + | '''[[Efavirenz|EFAVIRENZ]]/EMTRICITABINA/[[Tenofovir|TENOFOVIR DISOPROXIL]]''' |
*'''[[Atripla]]''' [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000797/WC500028103.pdf''monografia''] 30CPR RIV600+200+245MG | *'''[[Atripla]]''' [http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Summary_for_the_public/human/000797/WC500028103.pdf''monografia''] 30CPR RIV600+200+245MG | ||
Versione delle 00:58, 5 mag 2012
Indice
SPECIALITÀ
EMTRICITABINA
- Emtriva monografia 1FL 30CPS 200MG, OS SOL 1FL 170ML
EMTRICITABINA/TENOFOVIR DISOPROXIL
- Truvada monografia 30CPR RIV 200MG/245MG
EFAVIRENZ/EMTRICITABINA/TENOFOVIR DISOPROXIL
- Atripla monografia 30CPR RIV600+200+245MG
STRUTTURA
